Skip to content
OpenCapital
Get started

Contineum Therapeutics, Inc. CTNM Q4 2025 Annual earnings

Reported March 5, 2026 · Before market open

EPS-$0.49Beat by $0.01
Revenue estimate$7.5M
EPS estimate-$0.50

Next report

Aug 4, 2026 (In 6 days)
EPS estimate-$0.46

Versus estimates

Diluted EPS

Q1 2026-$0.39Beat by $0.16
Q4 2025-$0.49Beat by $0.01
Q3 2025-$0.45Beat by $0.13Q2 2025-$0.62Miss by $0.06Q1 2025-$0.62Miss by $0.06Q4 2024-$0.56Miss by $0.12

Ask the moment Contineum Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Contineum Therapeutics, Inc. report Q4 2025 earnings?
Contineum Therapeutics, Inc. (CTNM) reported Q4 2025 earnings on March 5, 2026 before market open.
What were Contineum Therapeutics, Inc.'s Q4 2025 revenue and EPS?
Contineum Therapeutics, Inc. reported eps of $-0.49 for Q4 2025.
Did Contineum Therapeutics, Inc. beat estimates in Q4 2025?
EPS beat the consensus estimate of $-0.50 by $0.01.
How did Contineum Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 12.5% from $-0.56.
Where can I find Contineum Therapeutics, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001628280-26-015159) and the 10-K periodic report (0001628280-26-015165) directly on SEC EDGAR. The filing index links above go to sec.gov.